Related stories
Coca-Cola Europacific Partners Sees 2026 Revenue Growth of 3% to 4%
M impact | EARNINGS | Nov 03, 2026, 07:14 AM UTC
Shield Therapeutics No Longer Expects 2026 Operating Profitability
The company no longer expects the group to achieve operating profitability for the year ending 31 December 2026.
M impact | EARNINGS | Nov 03, 2026, 07:05 AM UTC
Zydus Wellness Reports September-Quarter Consolidated Net Profit of 51 Million Rupees
M impact | EARNINGS | Nov 03, 2026, 07:05 AM UTC
Verisure Expects FY2026 ARR Growth of 9.0%-9.5%
Verisure expects FY2026 adjusted EBIT margin of 26.5% and free cash flow of €200 million.
M impact | EARNINGS | Nov 03, 2026, 07:05 AM UTC
TP ICAP Group 3Q Revenue Rose 11% at Constant Currency
M impact | EARNINGS | Nov 03, 2026, 07:04 AM UTC
Solar Reports Q3 Adjusted Free Cash Flow of DKK -155 Million
M impact | EARNINGS | Nov 03, 2026, 07:04 AM UTC